← Open Payments lookup

ALEXA NACEANCENO: Open Payments

NPI 1952867731 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,606 in 87 payments from 30 companies in 2025. Trend: 2023 $2,434 · 2024 $1,422 · 2025 $1,606

Food & beverage: $1,606
CompanyPaymentsAmount
Novo Nordisk Inc9$170
Dexcom, Inc.17$165
Madrigal Pharmaceuticals5$104
Lilly USA, LLC5$87
Novartis Pharmaceuticals Corporation4$83
Corcept Therapeutics4$82
Amgen Inc.4$74
Xeris Pharmaceuticals, Inc.3$61
SANOFI-AVENTIS U.S. LLC2$61
BETA BIONICS, INC.3$58

Products named: Dexcom G6 Transmitter, REZDIFFRA, MOUNJARO, Ozempic, LEQVIO, Korlym, TZIELD, iLet Bionic Pancreas.

Industry payments across MO — which companies pay providers there.